Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Long-Term Investments (2021 - 2025)

Historic Long-Term Investments for Korro Bio (KRRO) over the last 4 years, with Q3 2025 value amounting to $10.0 million.

  • Korro Bio's Long-Term Investments fell 6881.83% to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year decrease of 6881.83%. This contributed to the annual value of $37.0 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Korro Bio reported Long-Term Investments of $10.0 million as of Q3 2025, which was down 6881.83% from $23.3 million recorded in Q2 2025.
  • Over the past 5 years, Korro Bio's Long-Term Investments peaked at $37.0 million during Q4 2024, and registered a low of $6.6 million during Q2 2021.
  • Over the past 4 years, Korro Bio's median Long-Term Investments value was $17.8 million (recorded in 2021), while the average stood at $19.5 million.
  • Within the past 5 years, the most significant YoY rise in Korro Bio's Long-Term Investments was 2332.74% (2025), while the steepest drop was 6881.83% (2025).
  • Quarter analysis of 4 years shows Korro Bio's Long-Term Investments stood at $11.7 million in 2021, then tumbled by 36.77% to $7.4 million in 2022, then skyrocketed by 398.77% to $37.0 million in 2024, then tumbled by 72.91% to $10.0 million in 2025.
  • Its last three reported values are $10.0 million in Q3 2025, $23.3 million for Q2 2025, and $24.0 million during Q1 2025.